Revisiting opioid risk assessment
- PMID: 41086309
- DOI: 10.1097/j.pain.0000000000003791
Revisiting opioid risk assessment
References
-
- Collins CL, England K, Conrad S, Day H, Tilahun E, Dal Pan G, Meyer T. Patient-reported duration of opioid analgesic use after discharge from surgical procedures or other types of acute pain: a scoping review. Pain Med 2025;26:pnaf029.
-
- Jani M, Girard N, Bates DW, Buckeridge DL, Dixon WG, Tamblyn R. Comparative risk of mortality in new users of prescription opioids for noncancer pain: results from the International Pharmacosurveillance Study. PAIN 2025;166:1118–27.
-
- Jannetto PJ. The North American opioid epidemic. Ther Drug Monit 2021;43:1–5.
-
- Lawson CA, Mamas MA, Jones PW, Teece L, McCann G, Khunti K, Kadam UT. Association of medication intensity and stages of airflow limitation with the risk of hospitalization or death in patients with heart failure and chronic obstructive pulmonary disease. JAMA Netw Open 2018;1:e185489.
-
- Yeo Y, Johnson R, Heng C. The public health approach to the worsening opioid crisis in the United States calls for harm reduction strategies to mitigate the harm from opioid addiction and overdose deaths. Mil Med 2022;187:244–7.
LinkOut - more resources
Full Text Sources
